Published in Nucleic Acid Ther on August 03, 2012
Oligonucleotide aptamers: new tools for targeted cancer therapy. Mol Ther Nucleic Acids (2014) 1.49
A review of therapeutic aptamer conjugates with emphasis on new approaches. Pharmaceuticals (Basel) (2013) 0.99
Aptamers as a novel tool for diagnostics and therapy. Invest New Drugs (2015) 0.80
Recent Advances in Aptamers Targeting Immune System. Inflammation (2017) 0.75
Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem (1999) 5.22
How much will Herceptin really cost? BMJ (2006) 3.23
Aptamer:toxin conjugates that specifically target prostate tumor cells. Cancer Res (2006) 2.23
Avoiding twisted pixels: ethical guidelines for the appropriate use and manipulation of scientific digital images. Sci Eng Ethics (2010) 2.18
The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions. MAbs (2010) 1.86
Nano-bio-chip sensor platform for examination of oral exfoliative cytology. Cancer Prev Res (Phila) (2010) 1.76
Discovery and development of therapeutic aptamers. Annu Rev Pharmacol Toxicol (2010) 1.32
DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1-binding single-stranded DNA aptamers. Tumour Biol (2006) 1.29
Complement and cellular cytotoxicity in antibody therapy of cancer. Expert Opin Biol Ther (2008) 1.24
Phototoxic aptamers selectively enter and kill epithelial cancer cells. Nucleic Acids Res (2008) 1.23
Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid. Clin Exp Immunol (2003) 1.22
Targeted delivery of chemotherapy agents using a liver cancer-specific aptamer. PLoS One (2012) 1.06
The role of membrane complement regulatory proteins in cancer immunotherapy. Adv Exp Med Biol (2008) 1.05
Nucleic acid aptamers for target validation and therapeutic applications. J Biomol Tech (2005) 1.05
Identification of an aptamer targeting hnRNP A1 by tissue slide-based SELEX. J Pathol (2009) 1.04
CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9. J Physiol (2002) 1.02
Protection of the ischemic dog myocardium with carnitine. Am J Cardiol (1978) 1.00
DNA aptamers against the MUC1 tumour marker: design of aptamer-antibody sandwich ELISA for the early diagnosis of epithelial tumours. Anal Bioanal Chem (2007) 0.99
Complement-mediated killing of microtumors in vitro. Am J Pathol (1998) 0.93
In vitro antibacterial effects of antilipopolysaccharide DNA aptamer-C1qrs complexes. Folia Microbiol (Praha) (2008) 0.92
Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood. Nucl Med Biol (2000) 0.91
Neutralization of complement regulatory proteins augments lysis of breast carcinoma cells targeted with rhumAb anti-HER2. Immunopharmacology (1999) 0.90
Soluble MUC1 secreted by human epithelial cancer cells mediates immune suppression by blocking T-cell activation. Int J Cancer (1999) 0.88
Aptamer–biotin–streptavidin–C1q complexes can trigger the classical complement pathway to kill cancer cells. In Vitro Cell Dev Biol Anim (2010) 0.79
Selective glutaraldehyde-mediated coupling of proteins to the 3'-adenine terminus of polymerase chain reaction products. J Biomol Tech (2008) 0.78
Histochemical and structural changes in human myocardial cells after cardiopulmonary bypass. Circulation (1975) 0.78
Ultrastructural and physiological changes induced by atractylate in the canine myocardium. Cytobios (1976) 0.77
Activating transcription factor 3 (ATF3) expression in the neural retina and optic nerve of zebrafish during optic nerve regeneration. Comp Biochem Physiol A Mol Integr Physiol (2009) 0.95
Quantum dot-antibody and aptamer conjugates shift fluorescence upon binding bacteria. Biochem Biophys Res Commun (2004) 0.93
Diurnal and circadian retinomotor movements in zebrafish. Vis Neurosci (2005) 0.93
Astrocytes as gate-keepers in optic nerve regeneration--a mini-review. Comp Biochem Physiol A Mol Integr Physiol (2008) 0.91
Aptamer selection express: a novel method for rapid single-step selection and sensing of aptamers. J Biomol Tech (2008) 0.88
Discrete nuclear structures in actively growing neuroblastoma cells are revealed by antibodies raised against phosphorylated neurofilament proteins. BMC Neurosci (2003) 0.85
GFAP and nuclear lamins share an epitope recognized by monoclonal antibody J1-31. Brain Res (2003) 0.81
Fluorescence assay based on aptamer-quantum dot binding to Bacillus thuringiensis spores. J Fluoresc (2007) 0.81
Molecular and pharmacological characterization of muscarinic receptors in retinal pigment epithelium: role in light-adaptive pigment movements. J Neurochem (2005) 0.81
Phosphorylated neurofilaments and SNAP-25 in cultured SH-SY5Y neuroblastoma cells. Brain Res (2002) 0.81
Activation of muscarinic acetylcholine receptors elicits pigment granule dispersion in retinal pigment epithelium isolated from bluegill. BMC Neurosci (2004) 0.80
Uptake of 3H-cAMP by retinal pigment epithelium isolated from bluegill sunfish (Lepomis macrochirus). BMC Neurosci (2006) 0.78
Intermediate filaments of zebrafish retinal and optic nerve astrocytes and Müller glia: differential distribution of cytokeratin and GFAP. BMC Res Notes (2010) 0.78
Activating transcription factor 3 and reactive astrocytes following optic nerve injury in zebrafish. Comp Biochem Physiol C Toxicol Pharmacol (2011) 0.76
Carbachol-mediated pigment granule dispersion in retinal pigment epithelium requires Ca2+ and calcineurin. BMC Cell Biol (2007) 0.75
Development of a fluorescent enzyme-linked DNA aptamer-magnetic bead sandwich assay and portable fluorometer for sensitive and rapid leishmania detection in sandflies. J Fluoresc (2013) 0.75
Developmental expression of muscarinic receptors in the eyes of zebrafish. Brain Res (2011) 0.75
Electrochemiluminescence of dipicolinic acid (DPA) and (bpy)(2)Ru(DPA)(+) (bpy = 2,2'-bipyridine). Luminescence (2006) 0.75